This summary was created by AI, based on 1 opinions in the last 12 months.
Carl Zeiss Meditec (AFX-O) is a German company specializing in lenses for microscopes and laser surgery equipment, with a current price target of 83.58 Euros. The company's market value has decreased to 13x PE 2026, attributed to slowing sales in China and North America. However, it is considered an asset-lite company with substantial cash reserves and potential to benefit from a decline in interest rates. Overall, the company continues to face challenges in its core markets but holds significant potential for improvement.
Carl Zeiss Meditec is a OTC stock, trading under the symbol AFX-O on the (). It is usually referred to as or AFX-O
In the last year, there was no coverage of Carl Zeiss Meditec published on Stockchase.
Carl Zeiss Meditec was recommended as a Top Pick by on . Read the latest stock experts ratings for Carl Zeiss Meditec.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 0 stock analysts on Stockchase covered Carl Zeiss Meditec. The stock is worth watching.
On , Carl Zeiss Meditec (AFX-O) stock closed at a price of $.
They make lenses for microscopes used by surgeons, and mirrors for ASML. Share are down from 150 Euros due to slowing sales in China and North America. They also make laser surgery equipment. But it's an asset-lite company with tons of cash. It trades at 13x PE 2026. If interest rate decline, they will benefit.